Inflammatory Response and Treatment-Resistant Mental Disorders: Should Immunotherapy Be Added to Pharmacotherapy?

J Psychosoc Nurs Ment Health Serv. 2020 Jan 1;58(1):11-16. doi: 10.3928/02793695-20191218-03.

Abstract

Treatment resistance continues to challenge and frustrate mental health clinicians and provoke psychiatric researchers to seek additional explanatory theories for psychopathology. Because the inflammatory process activates symptoms of depression, anxiety, and psychosis, it is a reasonable route to follow for primary and/or indirect contribution to mental disorders. The current article reviews the research literature regarding the role the inflammatory process and immune system play in mental disorders as well as novel treatments under investigation for resistant depression, anxiety, substance use, and psychotic disorders. [Journal of Psychosocial Nursing and Mental Health Services, 58(1), 11-16.].

MeSH terms

  • Anxiety Disorders / therapy
  • Depressive Disorder, Treatment-Resistant / therapy
  • Humans
  • Mental Disorders / immunology
  • Mental Disorders / physiopathology*
  • Mental Disorders / therapy*
  • Psychoneuroimmunology*
  • Psychotic Disorders / therapy